HEBRARIUM
Why are the Jews
in cannabis?
Some questions arrive already poisoned.
That is not a serious market question.
It is an old prejudice looking for a new industry.
The serious question is different:
Why did Israel become important
in medical cannabis science, regulation and agricultural technology?
That question deserves an answer.
First, the trap.
Israel did not become important in cannabis
because it legalised recreational cannabis early.
It did not.
As of 2026, recreational cannabis in Israel is not a normal legal adult-use market. Personal use has been decriminalised in various forms, and medical cannabis is widely established, but this is not Colorado, California or Canada. Israel’s cannabis strength came mainly through medical cannabis, research, regulation and agritech — not through a fully open recreational market.
So if someone says, “They got ahead because they legalised”, the answer is:
No. They got ahead because
they studied.
Israel’s central cannabis advantage
begins with science.
Raphael Mechoulam and colleagues identified the structures of CBD and THC in the 1960s. THC was isolated and structurally characterised in 1964, and later Mechoulam’s work helped open the modern field of endocannabinoid research, including anandamide in 1992 and 2-AG in 1995.
That matters.
Cannabis was not simply “known” in Israel. It was studied there at a level that shaped global cannabinoid science.
The plant did not enter through folklore alone.
It entered through chemistry.
Israel’s medical cannabis programme
began early.
A 2025 review notes that medical cannabis received initial approval in Israel in 1992 and then developed through major regulatory and structural transformations.
That early medical framework created something very different from a recreational hype market: patients, doctors, researchers, cultivation standards, pharmacies, clinical questions, government agencies, product categories, quality control and data.
Not perfect. Not free of commercial pressure. But serious.
A country does not need recreational dispensaries to build medical cannabis knowledge.
It needs permission to research, treat, regulate and improve.
And how did they learn this
in the desert?
That question sounds funny until it becomes stupid.
Israel has long invested heavily in agricultural technology because water, climate and land pressure
made agriculture a technical problem from the beginning.
Drip irrigation, greenhouse systems, fertigation, protected cultivation, seed work, desert agriculture, sensors and agronomic optimisation are not side hobbies there. They are survival technologies.
So when cannabis entered that ecosystem,
it did not enter an empty field.
It entered a country
already trained to treat plants as controlled biological systems.
That is not conspiracy. That is infrastructure.
There is basis for the “no-high” cannabis story,
but again we must speak carefully.
In 2012, reports described Tikun Olam’s CBD-rich, very low-THC cultivar Avidekel, containing high CBD and less than 1% THC. Reuters quoted Mechoulam saying it was thought to be the first CBD-enriched cannabis plant with no THC developed in Israel, while also noting that the industry was not organised enough to track every company globally.
So the clean version is:
Israel was early and visible
n CBD-rich / low-THC medical cannabis breeding,
but “first” claims should be handled cautiously.
The conspiracy appears
because people see success
and skip the infrastructure.
They see a group they already suspect.
Then they call suspicion analysis.
That is not analysis.
It is laziness with an enemy.
Israel’s cannabis role should
be studied critically.
But ethnicity is not an explanation.
If someone wants to understand Israeli cannabis, the path is clear:
Mechoulam. Hebrew University. Medical cannabis since the early 1990s. Agritech. Water scarcity. Controlled cultivation. Clinical research. Regulatory infrastructure. Export ambition. Patient demand. High-tech culture…
That is the story.
Not bees around money.
The vulgar version says:
They ran where the money was.
The educated version says:
They were already standing where the science,
medicine and agritech met.
That is why they moved fast when cannabis became visible.
The lesson is not ethnic. The lesson is educational:
Study early. Build infrastructure.
Take plants seriously before the market arrives.
Join early.
Keep the archive open.
The VADEMECUM is becoming a living archive of guides, tools, notes and practical plant knowledge.
Free member access. Join early. Keep the archive open.
Join early.
Keep the
archive open.
The VADEMECUM is not just a book anymore. It is becoming a living archive of guides, tools, notes and practical plant knowledge.
Free member access. Join early. Keep the archive open.
The VADEMECUM is becoming a living archive of practical plant knowledge.
Free member access.